Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Study of E7386 in Combination With Other Anticancer Drugs in Solid Tumors
jRCT2080224780Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2019
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of e7386 in hepatocellular carcinoma (HCC), colorectal cancer (CRC), endometrial cancer (EC) and 1 more (3 arms), sponsored by Eisai Co., Ltd. Started Jul 2019; status: completed.
02
Drugs
e7386
03
Conditions
hepatocellular carcinoma (HCC)colorectal cancer (CRC)endometrial cancer (EC)Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080224780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224780.